top of page
Steglujan is used in combination with diet and exercise to manage type 2 diabetes in adults. Steglujan consists of ertugliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, and sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Fact Table Formula C22H25ClO7, C16H15F6N5O License US DailyMed, US FDA, EU EMA Bioavailability ~100%,87% Legal status Rx-Only Chemical Name Ertugliflozin / Sitagliptin Elimination half-life ~17 hours, 8 to 14 h Dosage (Strength) 5mg/100mg, 15mg/100mg Pregnancy Consult Doctor Brands Steglujan Protein binding 93.6%, 38% PubChem CID 44814423, 4369359 MedlinePlus a606023 ChEBI 40237 ATC code A10BK04, A10BH01 DrugBank DB11827, DB01261 KEGG D10313, D08516 Routes of administration By mouth

Steglujan (Ertugliflozin/Sitagliptin)

  • Steglujan comes in tablets with the following strengths: Ertugliflozin 5 mg and sitagliptin 100 mg Ertugliflozin 15 mg and sitagliptin 100 mg Once you have a prescription and buy Steglujan, then Steglujan is taken by mouth once daily in the morning with or without food. The dose may range from 5 mg ertugliflozin/100 mg sitagliptin by mouth once daily to 15 mg ertugliflozin/100 mg sitagliptin by mouth once daily, depending on toleration and the need for more blood sugar control.
bottom of page